Cetromed is a Life Sciences holding company located in Belgium, acquired by NetScientific in 2021. Centromed is invested in several spin-outs of K.U. Leuven, a leading European research institution.
Cetromed’s portfolio consists of:
FOx Biosystems
FOx Biosystems provides real-time, label-free analysis technology based on an innovative fibre-optic-based surface plasmon resonance biosensor, enabling users to generate high quality biomolecular data such as affinity data, kinetic data and concentration measurements. The company is backed by LRM, Heran Partners, K.U. Leuven’s Gemma Frisius Fund, and Leuven University.DName-iT
DName-iT is developing biological barcodes to provide improved quality assurance through the entire genetic testing process. This technology offers a new level of traceability and quality control to the workflow of genetic tests based on Next Generation Sequencing (NGS) and beyond.Oncocidia
Oncocidia is developing a targeted radiopharmaceutical cancer treatment, which involves extending the already successful use of Iodine-131 in treating thyroid cancer, to treat solid cancers elsewhere in the body.
